当前位置： SCI文献检索 > HIV MEDICINE期刊下所有文献 > Paediatric antiretroviral therapy audit in South London.

Paediatric antiretroviral therapy audit in South London.

Abstract：

OBJECTIVES:To audit clinical and surrogate marker outcome data following the introduction of combination antiretroviral therapy to HIV-infected children in South London. METHODS:We performed a retrospective cohort study of 110 HIV-infected children under the care of the Paediatric HIV in South London Network (PHILS-NET) from January 1996 to September 1999. The following were identified: type of antiretroviral therapy used; duration of therapy; toxicity; impact on viral load and CD4 count; reasons for changing therapy; and clinical progression. RESULTS:Ninety-one (83%) of the 110 children (55 females; median age 6.3 years) received 166 antiretroviral therapy regimens. Sixty per cent of the regimens were triple therapy: either two nucleoside reverse transcriptase inhibitors (NRTIs) and one protease inhibitor (58; 34.9%) or two NRTIs and one non-nucleoside reverse transcriptase inhibitor (39; 23.5%). The mean duration of completed therapy was 46 weeks for first line therapy with a standard deviation (SD) of 38 weeks and 40 weeks in third line therapy with an SD of 22 weeks. Changes in antiretroviral regimens were owing to virological failure in 60% and toxicity in 10%. Overall, 46% of children on first line and 37% on second line antiretroviral therapy achieved an undetectable viral load of < 400 HIV-1 RNA copies/mL. Clinical progression for the whole cohort fell from 3.7% per year for children on dual therapy to 0.7% per year for children on highly active antiretroviral therapy. CONCLUSIONS:This audit shows the clinical benefit of antiretroviral therapy use in a cohort of children with moderately advanced HIV disease. The surrogate outcome data seen for the viral load and CD4 count are similar to those of reports from clinical trials. Antiretroviral therapy regimens were sequenced rapidly, mainly owing to virological failure.

journal_name

HIV Med

journal_title

HIV medicine

authors

Doerholt K,Sharland M,Ball C,DuMont G

doi

10.1046/j.1464-2662.2001.00098.x

keywords:

subject

Has Abstract

pub_date

2002-01-01 00:00:00

pages

44-8

issue

1

eissn

1464-2662

issn

1468-1293

pii

0098

journal_volume

3

pub_type

杂志文章

相关文献

HIV MEDICINE文献大全
  • Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.

    abstract：OBJECTIVES:The objective of this study was to seek correlates of immune protection in HIV infection. We sought to elucidate the association between the presence of human leucocyte antigen (HLA) alleles, as well as killer immunoglobulin receptor (KIR) genotypes, and the susceptibility to HIV infection in a Spanish cohor...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12494

    authors： Rallón N,Restrepo C,Vicario JL,Del Romero J,Rodríguez C,García-Samaniego J,García M,Cabello A,Górgolas M,Benito JM

    更新日期：2017-09-01 00:00:00

  • GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.

    abstract：OBJECTIVES:To evaluate the benefits of therapeutic drug monitoring (TDM) in association with genotypic resistance testing and expert advice to optimize therapy in multiexperienced patients infected with HIV-1. METHODS:Patients with a viral load>1000 HIV-1 RNA copies/mL and an unchanged antiretroviral therapy regimen o...

    journal_title：HIV medicine

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1111/j.1468-1293.2004.00234.x

    authors： Bossi P,Peytavin G,Ait-Mohand H,Delaugerre C,Ktorza N,Paris L,Bonmarchand M,Cacace R,David DJ,Simon A,Lamotte C,Marcelin AG,Calvez V,Bricaire F,Costagliola D,Katlama C

    更新日期：2004-09-01 00:00:00

  • HIV prevalence and HIV clinical outcomes of transgender and gender-diverse people in England.

    abstract：OBJECTIVES:We provide the first estimate of HIV prevalence among trans and gender-diverse people living in England and compare outcomes of people living with HIV according to gender identity. METHODS:We analysed a comprehensive national HIV cohort and a nationally representative self-reported survey of people accessin...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12987

    authors： Kirwan PD,Hibbert M,Kall M,Nambiar K,Ross M,Croxford S,Nash S,Webb L,Wolton A,Delpech VC

    更新日期：2021-02-01 00:00:00

  • Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

    abstract：OBJECTIVES:Antiretroviral therapy during pregnancy is recommended to reduce the risk of mother-to-child transmission of HIV and for maternal care management. Physiological changes during pregnancy can affect pharmacokinetics, potentially altering pharmacological activity. We therefore evaluated the pharmacokinetics of ...

    journal_title：HIV medicine

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1111/hiv.12047

    authors： Zorrilla CD,Wright R,Osiyemi OO,Yasin S,Baugh B,Brown K,Coate B,Verboven P,Mrus J,Falcon R,Kakuda TN

    更新日期：2014-01-01 00:00:00

  • HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance.

    abstract：OBJECTIVES:In recent years, new technologies and new approaches to scale up HIV testing have emerged. The objective of this paper was to synthesize the body of recent evidence on strategies aimed at increasing the uptake and coverage of HIV testing outside of health care settings in the European Union (EU)/European Eco...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12807

    authors： Croxford S,Tavoschi L,Sullivan AK,Combs L,Raben D,Delpech V,Jakobsen SF,Amato-Gauci AJ,Desai S

    更新日期：2020-03-01 00:00:00

  • The Recent Infection Testing Algorithm (RITA) in clinical practice: a survey of HIV clinicians in England and Northern Ireland.

    abstract：OBJECTIVES:In order to estimate HIV incidence among high-risk groups, in January 2009 the Health Protection Agency introduced the Recent Infection Testing Algorithm (RITA) in England and Northern Ireland (E&NI), currently the only regions to inform patients of RITA results. This survey of HIV specialists aimed to inves...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2012.00990.x

    authors： Garrett Nj,Lattimore S,Gilbart V,Aghaizu A,Mensah G,Tosswill J,Murphy G,Delpech V

    更新日期：2012-08-01 00:00:00

  • Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.

    abstract：OBJECTIVES:Dyslipidaemia has become a common problem in HIV disease, especially in patients on current antiretroviral therapy. However, the pathogenic mechanisms involved are not well understood or documented using conventional lipid measurements. METHODS:Using a cross-sectional design, the prevalence of abnormal stan...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2005.00316.x

    authors： Rimland D,Guest JL,Hernández I,Del Rio C,Le NA,Brown WV

    更新日期：2005-09-01 00:00:00

  • De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savings.

    abstract：OBJECTIVES:As more HIV-positive individuals receive antiretroviral therapy (ART), payers are seeking options for covering these increased and sustained drug costs. Strategic use of available generic antiretroviral (ARV) formulations may be feasible. De-simplifying a single-tablet co-formulation (STF) into two or more t...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12701

    authors： Krentz HB,Campbell S,Lahl M,Gill MJ

    更新日期：2019-03-01 00:00:00

  • Monitoring HIV-indicator condition guided HIV testing in Estonia.

    abstract：OBJECTIVES:The aim of the study was to assess indicator condition (IC) guided HIV testing in Estonia from 2012-2015. METHODS:We used Estonian Health Insurance Fund (EHIF) data. EHIF is the core purchaser of health care services in Estonia, covering health care costs for insured people (94% of the total population). Af...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12586

    authors： Rüütel K,Lemsalu L,Lätt S,OptTEST by HiE.

    更新日期：2018-02-01 00:00:00

  • Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.

    abstract：OBJECTIVES:The aim of the study was to explore the awareness of rectal microbicides, the use of pre-exposure prophylaxis (PREP) and the willingness to participate in biomedical HIV prevention trials in a cohort of HIV-negative gay men. METHODS:In a community-based cohort study, HIV-negative homosexually active men in ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2009.00777.x

    authors： Poynten IM,Jin F,Prestage GP,Kaldor JM,Imrie J,Grulich AE

    更新日期：2010-04-01 00:00:00

  • Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients.

    abstract：OBJECTIVES:Our objective was to identify patient factors associated with being untreated for hepatitis C virus (HCV) infection in HIV-coinfected patients. METHODS:A prospective longitudinal study was carried out. HIV-infected patients with active chronic HCV infection included in the HERACLES cohort (NCT02511496) cons...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/hiv.12715

    authors： Rivero-Juarez A,Tellez F,Castaño-Carracedo M,Merino D,Espinosa N,Santos J,Macias J,Paniagua-García M,Zapata-Lopez A,Collado A,Gómez-Vidal MA,Perez-Stachowski J,Muñoz-Medina L,Fernandez-Fuertes E,Rivero A,Grupo de estudio de

    更新日期：2019-07-01 00:00:00

  • Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.

    abstract：OBJECTIVES:We evaluated the efficacy and tolerability of lamivudine + dolutegravir in a cohort of HIV-1 infected, treatment-experienced patients with undetectable HIV-RNA. METHODS:Time to treatment discontinuation (TD) and virological failure (VF) and their predictors were assessed in a multicenter cohort of HIV-1 inf...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12611

    authors： Borghetti A,Baldin G,Lombardi F,Ciccullo A,Capetti A,Rusconi S,Sterrantino G,Latini A,Cossu MV,Gagliardini R,De Luca A,Di Giambenedetto S

    更新日期：2018-03-24 00:00:00

  • Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.

    abstract：OBJECTIVES:People with HIV (PWHIV) are likely to need therapies for comorbidities as they age. We assessed risk of drug-drug interactions (DDIs) in PWHIV. METHODS:The Climate-HIV electronic recording system was used to cross-sectionally analyse records from PWHIV aged ≥ 18 years attending four UK HIV units with a curr...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12879

    authors： Okoli C,Schwenk A,Radford M,Myland M,Taylor S,Darley A,Barnes J,Fox A,Grimson F,Reeves I,Munshi S,Croucher A,Boxall N,Benn P,Paice A,van Wyk J,Khoo S

    更新日期：2020-09-01 00:00:00

  • A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults.

    abstract：OBJECTIVES:To compare the safety and efficacy of amprenavir [APV/j Agenerase trade mark; GlaxoSmithKline, [Ware, UK; 600 mg twice a day (bid)] boosted with low-dose ritonavir (RTV, 100 mg bid) with those of other protease inhibitors (PIs) in PI-experienced HIV-infected patients. STUDY DESIGN:Parallel-group, randomized...

    journal_title：HIV medicine

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1111/j.1468-1293.2004.00224.x

    authors： Pulido F,Katlama C,Marquez M,Thomas R,Clumeck N,Pedro Rde J,Cattelan AM,Zhu C,Tymkewycz P

    更新日期：2004-07-01 00:00:00

  • The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily.

    abstract：:Tenofovir (TDF) co-administered with didanosine (ddI) 400 mg increases ddI plasma concentrations by up to 60%, raising concerns over toxicity. To limit this interaction, the dosage of ddI may be reduced to 250 mg once daily when co-prescribed with TDF. In this clinical cohort, highly active antiretroviral therapy regi...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2005.00279.x

    authors： Tung MY,Mandalia S,Bower M,Gazzard B,Nelson M

    更新日期：2005-05-01 00:00:00

  • Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease.

    abstract：BACKGROUND:Recent studies in hospitalized patients with community-acquired pneumonia have found a lower risk of bacteraemia and better clinical outcomes in patients who had previously received the 23-valent pneumococcal polysaccharide vaccine (PPV) in comparison with unvaccinated individuals. The aim of this study was ...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2009.00695.x

    authors： Imaz A,Falcó V,Peñaranda M,Jordano Q,Martínez X,Nadal C,Curran A,Planes AM,Dalmau D,Ribera E,Riera M,Ruiz de Gopegui E,Pahissa A

    更新日期：2009-07-01 00:00:00

  • Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response.

    abstract：OBJECTIVES:To investigate the concordance between any of the results of nine HIV-1 drug-resistance interpretation systems (ISs) and their ability to predict week 8 and week 24 virological responses to abacavir-containing combination therapy. PATIENTS AND METHODS:A total of 1306 HIV-infected patients with a viral load ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2008.00523.x

    authors： Cozzi-Lepri A,Standardization and Clinical Relevance of HIV Drug Resistance Testing Project for the Forum for Collaborative HIV Research.

    更新日期：2008-01-01 00:00:00

  • HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.

    abstract：:The advent of potent highly active antiretroviral therapy (HAART) for persons infected with HIV-1 has led to a "new" chronic disease with complications including cardiovascular disease (CVD). CVD is a significant cause of morbidity and mortality in persons with HIV infection. In addition to traditional risk factors su...

    journal_title：HIV medicine

    pub_type： 杂志文章,评审

    doi：10.1111/hiv.12346

    authors： Lambert CT,Sandesara PB,Hirsh B,Shaw LJ,Lewis W,Quyyumi AA,Schinazi RF,Post WS,Sperling L

    更新日期：2016-06-01 00:00:00

  • HIV testing in community settings in resource-rich countries: a systematic review of the evidence.

    abstract：OBJECTIVES:Community HIV testing represents an opportunity for diagnosing HIV infection among individuals who may not have contact with health services, especially in hard-to-reach groups. The aim of this review was to assess the evidence for feasibility, acceptability and effectiveness of HIV testing strategies in com...

    journal_title：HIV medicine

    pub_type： 杂志文章,评审

    doi：10.1111/j.1468-1293.2012.00992.x

    authors： Thornton AC,Delpech V,Kall MM,Nardone A

    更新日期：2012-08-01 00:00:00

  • Utilization of absolute monocyte counts to predict cardiovascular events in people living with HIV.

    abstract：OBJECTIVES:Cardiovascular risk is increased in people living with HIV (PLWH). In HIV-uninfected populations, total absolute monocyte count (AMC) has been shown to be predictive of future cardiovascular events (CVEs). We sought to determine whether AMC predicts CVEs in PLWH independent of established and HIV-related car...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.13018

    authors： Bogorodskaya M,Lyass A,Mahoney TF,Borowsky LH,Sen P,Swirski FK,Srinivasa S,Longenecker CT,Massaro JM,D'Agostino RB Sr,Triant VA

    更新日期：2020-12-08 00:00:00

  • The case for indicator condition-guided HIV screening.

    abstract：:One-half of the estimated 2.5 million people who now live with HIV in the World Health Organization (WHO) European Region are still diagnosed late. A central question is which clinical scenarios should trigger an HIV test recommendation in order to avoid late presentation. Drawing on the work of the HIV Indicator Dise...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12022

    authors： Lazarus JV,Hoekstra M,Raben D,Delpech V,Coenen T,Lundgren JD,HIV in Europe Initiative Steering Committee.

    更新日期：2013-08-01 00:00:00

  • Associations of marijuana with markers of chronic lung disease in people living with HIV.

    abstract：OBJECTIVES:The relationship between marijuana use and markers of chronic lung disease in people living with HIV (PLWH) is poorly understood. METHODS:We performed a cross-sectional analysis of the Examinations of HIV-Associated Lung Emphysema (EXHALE) study, including 162 HIV-positive patients and 138 participants with...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12966

    authors： Wenger DS,Triplette M,Shahrir S,Akgun KM,Wongtrakool C,Brown ST,Kim JW,Soo Hoo GW,Rodriguez-Barradas MC,Huang L,Feemster LC,Zifodya J,Crothers K

    更新日期：2021-02-01 00:00:00

  • Correlating HIV tropism with immunological response under combination antiretroviral therapy.

    abstract：OBJECTIVES:A significant percentage of patients infected with HIV-1 experience only suboptimal CD4 cell recovery while treated with combination therapy (cART). It is still unclear whether viral properties such as cell tropism play a major role in this incomplete immune response. This study therefore intended to follow ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12365

    authors： Bader J,Schöni-Affolter F,Böni J,Gorgievski-Hrisoho M,Martinetti G,Battegay M,Klimkait T,Swiss HIV Cohort Study.

    更新日期：2016-09-01 00:00:00

  • Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps.

    abstract：:Initiating antiretroviral therapy (ART) as early as the day of HIV diagnosis is a strategy of increasing global interest to control the HIV epidemic and optimize the health of people living with HIV (PLWH). No detrimental effects of rapid-start ART have been identified in randomized controlled trials undertaken in low...

    journal_title：HIV medicine

    pub_type： 杂志文章,评审

    doi：10.1111/hiv.12708

    authors： Boyd MA,Boffito M,Castagna A,Estrada V

    更新日期：2019-03-01 00:00:00

  • The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review.

    abstract：OBJECTIVES:The aim of the study was to assess the currently available evidence concerning the management of dyslipidaemias in HIV-infected individuals treated with antiretroviral therapy. METHODS:Randomized trials, published within the 5 years preceding 5 October 2005, were identified in PubMed Medline, Embase, and Th...

    journal_title：HIV medicine

    pub_type： 杂志文章,评审

    doi：10.1111/j.1468-1293.2007.00480.x

    authors： McGoldrick C,Leen CL

    更新日期：2007-09-01 00:00:00

  • A systematic review of risk of HIV transmission through biting or spitting: implications for policy.

    abstract：OBJECTIVES:The perceived threat of HIV transmission through spitting and biting is evidenced by the increasing use of "spit hoods" by Police Forces in the UK. In addition, a draft parliamentary bill has called for increased penalties for assaults on emergency workers, citing the risk of communicable disease transmissio...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12625

    authors： Cresswell FV,Ellis J,Hartley J,Sabin CA,Orkin C,Churchill DR

    更新日期：2018-04-23 00:00:00

  • Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection.

    abstract：OBJECTIVES:Although cognitive outcomes among perinatally infected youth have improved with highly active antiretroviral therapy (HAART), the impact of the age of initiation of treatment and the central nervous system (CNS) penetration effectiveness (CPE) of the regimen on cognitive outcomes is unknown. We aimed to desc...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12220

    authors： Lazarus JR,Rutstein RM,Lowenthal ED

    更新日期：2015-07-01 00:00:00

  • Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.

    abstract：OBJECTIVES:Few studies have explored the optimal dosing for efavirenz in individuals from China. We investigated plasma efavirenz concentrations and their association with efficacy and tolerance of efavirenz 600 mg daily in Chinese HIV-infected adults. METHODS:An analysis was performed using plasma samples from 455 pa...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12607

    authors： Guo F,Cheng X,Hsieh E,Du X,Fu Q,Peng W,Li Y,Song X,Routy JP,Li T

    更新日期：2018-05-15 00:00:00

  • Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit.

    abstract：OBJECTIVES:Mortality in young people with perinatally acquired HIV infection (PHIV) following transfer to adult care has not been characterized in the UK. We conducted a multicentre audit to establish the number of deaths and associated factors. METHODS:Fourteen adult clinics caring for infected young people reported ...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/hiv.12091

    authors： Fish R,Judd A,Jungmann E,O'Leary C,Foster C,HIV Young Persons Network (HYPNet).

    更新日期：2014-04-01 00:00:00

  • HIV treatment as prevention among men who have sex with men in the UK: is transmission controlled by universal access to HIV treatment and care?

    abstract：OBJECTIVES:In the UK, free HIV care is provided through dedicated HIV clinics. Using the national cohort of men who have sex with men (MSM) with diagnosed HIV infection and estimates of the number of undiagnosed men, we assessed whether high retention in HIV care and treatment coverage is sufficient to reduce HIV trans...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12066

    authors： Brown AE,Gill ON,Delpech VC

    更新日期：2013-10-01 00:00:00